SCHEMBL3974986

SCHEMBL3974986

CCOC(=O)c1occc1-c1cccc(OCc2ccccc2C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 2/20 0.44
ESR1 P03372 1/20 0.44
TP53 P04637 1/20 0.44
POLB P06746 1/20 0.44
APEX1 P27695 1/20 0.44
MAPK1 P28482 1/20 0.44
ESR2 Q92731 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CDK4 P11802 1/20 0.43
CCNB1 P14635 1/20 0.43
CCND1 P24385 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
MAOB P27338 1/20 0.43
PTGER1 P34995 1/20 0.41
PTGER3 P43115 1/20 0.41
PTGER2 P43116 1/20 0.41
FFAR1 O14842 5/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3981898 0.91 PTGER4 (0.42) PTGER4ESR1TP53POLBAPEX1
SCHEMBL3978696 0.85 PTGER4 (0.44) PTGER4ESR1TP53POLBAPEX1
SCHEMBL3977084 0.83 ALDH1A1 (0.52) POLBTDP1L3MBTL1FFAR1
SCHEMBL3979529 0.82 JAK2 (0.44) ESR1TP53L3MBTL1MAOBFFAR1
SCHEMBL3979355 0.82 MAPT (0.45) POLBMAPK1TDP1L3MBTL1
SCHEMBL3982814 0.80 POLB (0.41) PTGER4ESR1TP53POLBAPEX1
SCHEMBL3978230 0.80 PTGS2 (0.40) L3MBTL1FFAR1PPARG
SCHEMBL3977097 0.80 FNTA (0.46) ESR1TP53ESR2JAK2JAK3
SCHEMBL3975517 0.80 ALDH1A1 (0.42) MAOBPPARGJAK2JAK3
SCHEMBL27624303 0.80 PTGER4 (0.43) PTGER4ESR1TP53POLBAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 PTGER4 1074/4885ESR1 503/4885TP53 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.